Dietrick named chief value officer at Chesapeake Urology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

DANIEL DIETRICK was named chief value officer at Chesapeake Urology. His primary function is to oversee patient safety and healthcare quality. He will execute on the overall clinical vision and strategy of the organization, maintaining professional and quality control standards, and creating and overseeing processes to improve quality, efficiency, and cost effectiveness in Chesapeake Urology’s...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login